In the 2000s, the company received a technology transfer from a renowned osteosynthesis factory in New Jersey, United States. This chapter is considered a turning point in its history because, from then on, a passion for patient care merged with a relentless drive for productivity using cutting-edge technology.
This has allowed its implants to expand into the Latin American market, with a presence in Ecuador, the Dominican Republic, and Venezuela, becoming a benchmark in the manufacture of products for the reconstruction of fractures and bone malformations.
Internationalization, combined with a commitment to quality, has motivated us to work tirelessly to modernize our production processes and standardize our procedures. This is reflected in our certification under ISO 13485:2016, the quality management system for the manufacture and marketing of osteosynthesis products.
Currently, the main focus of IMEQ's strategy is on industrial growth and the optimization of production processes to strengthen competitiveness in a globalized market. This, without forgetting the driving force behind it: the rapid recovery and quality of life of our patients.